Dupilumab improves respiratory symptoms in patients with moderate-to-severe COPD with type 2 inflammation in phase 3 BOREAS trial

被引：0
|
作者：
Papi, Alberto [1 ]
Bhatt, Surya P. [2 ]
Rabe, Klaus F. [3 ,4 ]
Hanania, Nicola A. [5 ]
Vogelmeier, Claus F. [6 ]
Bafadhel, Mona [7 ]
Christenson, Stephanie A. [8 ]
Singh, Dave [9 ]
Laws, Elizabeth [10 ]
Maloney, Jennifer [11 ]
Lu, Xin [10 ]
Bauer, Deborah [10 ]
Bansal, Ashish [11 ]
Robinson, Lacey B. [12 ]
Abdulai, Raolat M. [12 ]
机构：
[1] Univ Ferrara, Ferrara, Italy
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] LungenClin Grosshansdorf, Grosshansdorf, Germany
[4] Christian Albrechts Univ Kiel, Airway Res Ctr North, German Ctr Lung Res, Grosshansdorf, Germany
[5] Baylor Coll Med, Houston, TX USA
[6] Philipps Univ Marburg, German Ctr Lung Res DZL, Marburg, Germany
[7] Kings Coll London, Kings Ctr Lung Hlth, London, England
[8] Univ Calif San Francisco, San Francisco, CA USA
[9] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester, England
[10] Sanofi, Bridgewater, NJ USA
[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[12] Sanofi, Cambridge, MA USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4786
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
    Hamilton, Jennifer D.
    Suarez-Farinas, Mayte
    Dhingra, Nikhil
    Cardinale, Irma
    Li, Xuan
    Kostic, Ana
    Ming, Jeffrey E.
    Radin, Allen R.
    Krueger, James G.
    Graham, Neil
    Yancopoulos, George D.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) : 1293 - 1300
  • [22] Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma
    Peters, Anju T.
    Sagara, Hironori
    Corren, Jonathan
    Domingo, Christian
    Altincatal, Arman
    Soler, Xavier
    Pandit-Abid, Nami
    Crikelair, Nora
    Rowe, Paul J.
    Jacob-Nara, Juby A.
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (04) : 477 - 484.e4
  • [23] DUPILUMAB IMPROVES AIRWAY OSCILLOMETRY, VENTILATION/PERFUSION, AND MUCUS PLUGGING IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA: THE VESTIGE TRIAL
    Washko, George
    Lipworth, Brian
    Saralaya, Dinesh
    Zhang, Mei
    Soler, Xavier
    Sacks, Harry
    Deniz, Yamo
    Rowe, Paul J.
    Gomez, Lucia De Prado
    Jacob-Nara, Juby A.
    CHEST, 2024, 166 (04) : 4819A - 4820A
  • [24] Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma
    Papi, Alberto
    Corren, Jonathan
    Castro, Mario
    Domingo, Christian
    Rogers, Linda
    Chapman, Kenneth R.
    Jackson, Daniel J.
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    Ortiz, Benjamin
    ALLERGY, 2023, 78 (01) : 233 - 243
  • [25] DUPILUMAB IMPROVES ABSENTEEISM IN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS COMPARED WITH PLACEBO IN PHASE 3 LIBERTY AD SOLO STUDIES
    de Bruin-Weller, M.
    Eckert, L.
    Gadkari, A.
    Msihid, J.
    Taniou, C.
    Chen, Q.
    Ardeleanu, M.
    Rossi, A.
    Chen, Z.
    Bego-Le Bagousse, G.
    VALUE IN HEALTH, 2018, 21 : S430 - S430
  • [26] Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
    Bronova, Irina
    Berdyshev, Evgeny
    Goleva, Elena
    Danby, Simon
    Bronoff, Anna Sofia
    Richers, Brittany
    Garcia, Shannon
    Gama, Marco Ramirez
    Taylor, Patricia
    Zahn, Joseph
    Agueusop, Inoncent
    Bafna, Shantanu
    Boguniewicz, Mark
    Ong, Peck
    Zhang, Annie
    Cork, Michael
    Leung, Donald
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB5 - AB5
  • [27] Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
    Berdyshev, Evgeny
    Goleva, Elena
    Bissonnette, Robert
    Bronova, Irina
    Bronoff, Anna Sofia
    Richers, Brittany N.
    Garcia, Shannon
    Ramirez-Gama, Marco
    Taylor, Patricia
    Praestgaard, Amy
    Agueusop, Inoncent
    Jurvilliers, Pauline
    Boguniewicz, Mark
    Levit, Noah A.
    Rossi, Ana B.
    Zhang, Annie
    Leung, Donald Y. M.
    ALLERGY, 2022, 77 (11) : 3388 - 3397
  • [28] Dupilumab Induces Clinical Remission in Patients With Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma
    Pavord, I. D.
    Israel, E.
    Szefler, S. J.
    Brusselle, G.
    Rabe, K. F.
    Chen, Z.
    Altincatal, A.
    Radwan, A.
    Pandit-Abid, N.
    Amin, N.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y. M.
    Khan, A.
    Lederer, D. J.
    Zhang, Y.
    Busse, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [29] Dupilumab Efficacy in Patients with Moderate-to-Severe Type 2 Asthma With and Without Elevated Blood Neutrophils
    Bleecker, E. R.
    Panettieri, R. A.
    Lugogo, N. L.
    Corren, J.
    Daizadeh, N.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Khodzhayev, A.
    Ortiz, B.
    Ferro, T. J.
    Hansen, C. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [30] Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST
    Wenzel, S. E.
    Pavord, I.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Hamilton, J. D.
    Swanson, B. N.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345